公司資料
Synlogic 股價、新聞與催化劑
- 股票代碼:
- SYBX
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
1.16 USD (0.00%)
收盤價
最後更新: 2026年9月17日
—
市值
股價為何變動
截至 2026年9月17日，SYBX 股價變化不大，收於 $1.16。目前新聞監測窗口內未發現新的同公司新聞。
公司概覽
業務概覽
Synlogic was a synthetic-biology company focused on engineered microbes and metabolic disease before its restructuring and decline. Its platform aimed to use living medicines to address rare disorders.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ before restructuring, Synlogic sat in synthetic biology and biotechnology.
商業模式特徵
The company depended on platform validation, clinical proof, and the ability to turn engineered-microbe science into value.
生技產業定位
Synlogic belongs to the historical synthetic-biology category rather than the current live public-company set.
未來催化劑
- Synlogic is now mostly a legacy and closeout story, so the catalysts are any strategic or asset-resolution update rather than a live pipeline milestone. The market is mainly waiting for clarity on what value, if any, remains.
近期新聞
新聞標題由機器翻譯，詳情為英文原文。
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。